Pyxis Oncology Raises $102.8 Million in Equity Offering

Pyxis Oncology has raised $102.8 million in net proceeds through an underwritten public offering of common stock, pre-funded warrants, and accompanying common warrants. The offering was led by Leerink, Guggenheim, and Wells Fargo, with shares priced at $2.90. The funds will support clinical development and corporate needs.